SME • IPO

Avience Biomedicals IPO (NSE SME) IPO

Back to IPO List

Minimum Investment

₹124,800

Price Range

₹196 to ₹208

Lot Size

600 shares

Issue Size

₹30 Cr

About the Company

Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions, focusing on biotechnology, genomics, and the IVD industry.

Issue Type

Bookbuilding IPO

IPO Objectives

Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
Funding the working capital requirements of the Company
General Corporate Purposes

Important Dates

Bid/Offer Opens On	18-06-2026
Bid/Offer Closes On	22-06-2026
Finalisation of Basis of Allotment	23-06-2026
Initiation of Refunds	24-06-2026
Credit of Shares to Demat	24-06-2026
IPO Listing Date	25-06-2026

Grey Market Premium (GMP)

₹40.00 per share

Last updated 15-06-2026 13:24

Registrar

Skyline Financial Services Pvt.Ltd.

Phone: 02228511022
Email: ipo@skylinerta.com
Website: https://www.skylinerta.com/ipo.php

Lead Managers

Fintellectual Corporate Advisors Pvt.Ltd.

Company Promoters

Mr. Dharam Deo Choudhary
Mr. Ram Nagina Choudhary
Mr. Janardan Pal and Ms. Deepa Choudhary.\r\n